We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-S.Korea signs new Pfizer vaccine deal; asks people to cut travel

Fri, 13th Aug 2021 09:07

(Recasts with Pfizer vaccine deal)

By Sangmi Cha

SEOUL, Aug 13 (Reuters) - South Korea on Friday signed a
deal to buy 30 million doses of Pfizer's COVID-19
vaccine for 2022, and the government urged people to cut holiday
travel amid a worsening fourth wave of infections and a slow
inoculation campaign.

Prime Minister Kim Boo-kyum asked companies to be flexible
about allowing people to work from home and urged those
returning from holiday to get tested, especially before clocking
in for work.

The government's efforts to curb fresh cases have been
stymied by the spread of the highly transmissible Delta variant,
which has made contact tracing hard in the peak summer travel
season. Supply bottlenecks at vaccine maker Moderna
have added to its problems.

South Korea has secured a total of 193 million doses of
vaccines, including from Pfizer, Moderna, AstraZeneca,
Johnson & Johnson and Novavax. It has fully
vaccinated 17.4% of its 52 million population.

Under an existing contract with Pfizer for 66 million doses
this year, the country has received 17.88 million.

Korea Disease Control and Prevention Agency (KDCA) Director
Jeong Eun-kyeong told a briefing on Friday that the doses under
the new Pfizer contract would start to arrive in the first
quarter of 2022, and South Korea had the option to buy another
30 million doses.

Separately, on Friday morning, a government delegation left
for Boston for talks with Moderna over the U.S. vaccine maker's
repeated shipment delays, health ministry official Son Young-rae
told a briefing.

Moderna told Seoul on Monday it would only be able to
deliver less than half the 8.5 million doses it was due to ship
this month. The country has a contract for 40 million doses from
Moderna, and has received around 2.5 million so far.

The KDCA reported 1,990 new COVID-19 infections for
Thursday, after a record daily count of 2,223 on Wednesday https://www.reuters.com/world/asia-pacific/south-koreas-daily-covid-19-cases-hit-record-surpassing-2200-health-minister-2021-08-10.

Total cases stand at 220,182, with 2,144 deaths, and the
government has said the current wave of infections has not
peaked yet.

Kim said the government would secure at least 5% of hospital
beds for serious COVID-19 cases in 26 general hospitals in the
capital Seoul and surrounding areas.

"There have been many workplace clusters recently," Kim told
a televised speech. "Please make sure the employees returning to
work to check for symptoms like fever."

Under the current distancing rules, employers are advised to
increase flexible staffing, with 30% of staff working remotely https://www.reuters.com/world/asia-pacific/south-korea-raise-covid-19-curbs-highest-level-seoul-says-pm-2021-07-08.

(Reporting by Sangmi Cha Editing by Sayantani Ghosh and Mark
Potter)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.